Well, the troubling thread here is that that may not be posssible using the amount of blood Theranos collects. Then the question becomes not only why is their valuation so high (which the public doesn't need to care too much about) but "how well do these traditional tests work with Theranos samples?"
That the answer could be "not very well" (and we haven't heard otherwise) is what's most troubling to me.